Naren L. Banik
Affiliations: | Medical University of South Carolina, Charleston, SC, United States |
Area:
Immunology, Neuroscience Biology, PharmacologyGoogle:
"Naren Banik"Mean distance: 21373.2
Children
Sign in to add traineeKurt E. Schaecher | grad student | 2001 | MUSC |
Eric A. Sribnick | grad student | 2005 | MUSC |
Mary K. Guyton | grad student | 2009 | MUSC |
Nicole N. Trager | grad student | 2013 | MUSC |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
McCoy HM, Polcyn R, Banik NL, et al. (2023) Regulation of enolase activation to promote neural protection and regeneration in spinal cord injury. Neural Regeneration Research. 18: 1457-1462 |
Myatich A, Haque A, Sole C, et al. (2022) Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury. Neural Regeneration Research. 18: 940-946 |
Haque A, Das A, Samantaray S, et al. (2022) Premarin Reduces Neurodegeneration and Promotes Improvement of Function in an Animal Model of Spinal Cord Injury. International Journal of Molecular Sciences. 23 |
Samantaray S, Knaryan VH, M Del Re A, et al. (2020) Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP. Neurotoxicity Research |
Cox A, Capone M, Matzelle D, et al. (2020) Nanoparticle based estrogen delivery to spinal cord injury site reduces local parenchymal destruction and improves functional recovery. Journal of Neurotrauma |
Polcyn R, Capone M, Matzelle D, et al. (2020) Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury. Neurochemistry International. 104788 |
Haque A, Samantaray S, Knaryan VH, et al. (2020) Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Experimental Neurology. 113315 |
Polcyn R, Capone M, Matzelle D, et al. (2019) Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibition. Metabolic Brain Disease |
Shams R, Banik NL, Haque A. (2019) Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease. Progress in Molecular Biology and Translational Science. 167: 107-124 |
Chandran R, Capone M, Matzelle D, et al. (2018) Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report. Neurochemical Research |